(Q51901947)

17 April 2018

title

Influence of medication choice and comorbid diabetes: the cost of bipolar disorder in a privately insured US population. (English)

1 reference

17 April 2018

1 reference

Carolyn Harley

1

1 reference

17 April 2018

Hong Li

2

1 reference

17 April 2018

Patricia Corey-Lisle

3

1 reference

17 April 2018

Gilbert J L'Italien

4

1 reference

17 April 2018

William Carson

5

1 reference

17 April 2018

publication date

29 June 2007

1 reference

17 April 2018

Social Psychiatry and Psychiatric Epidemiology

published in

1 reference

17 April 2018

volume

42

1 reference

17 April 2018

issue

9

1 reference

17 April 2018

page(s)

690-697

1 reference

17 April 2018

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00127-007-0222-Z

Health care utilization and costs among patients treated for bipolar disorder in an insured population.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00127-007-0222-Z

Cost of treating bipolar disorder in the California Medicaid (Medi-Cal) program

21 January 2018

1 reference

12 December 2020

Incidence of newly diagnosed diabetes attributable to atypical antipsychotic medications

1 reference

12 December 2020

Divalproex sodium versus olanzapine in the treatment of acute mania in bipolar disorder: health-related quality of life and medical cost outcomes.

1 reference

12 December 2020

Health care utilization and costs among privately insured patients with bipolar I disorder

1 reference

12 December 2020

The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998.

1 reference

12 December 2020

Atypical antipsychotics and glucose dysregulation: a systematic review

1 reference

12 December 2020

Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania. Results from a randomized controlled trial

1 reference

12 December 2020

Exploring the association between atypical neuroleptic agents and diabetes mellitus in older adults

1 reference

12 December 2020

Insurance expenditures on bipolar disorder: clinical and parity implications

1 reference

12 December 2020

Comparative study of the development of diabetes mellitus in patients taking risperidone and olanzapine

1 reference

12 December 2020

An economic evaluation of manic-depressive illness--1991.

1 reference

12 December 2020

The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large U.S. employers in 1999.

1 reference

12 December 2020

Rate of new-onset diabetes among patients treated with atypical or conventional antipsychotic medications for schizophrenia

1 reference

12 December 2020

Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities

1 reference

12 December 2020

Consensus development conference on antipsychotic drugs and obesity and diabetes

1 reference

12 December 2020

Medical resource use among patients treated for bipolar disorder: a retrospective, cross-sectional, descriptive analysis.

1 reference

12 December 2020

Prevalence of mood disorders in a national sample of young American adults

1 reference

12 December 2020

Atypical antipsychotic drugs and diabetes mellitus in a large outpatient population: a retrospective cohort study

1 reference

12 December 2020

Retrospective cohort study of diabetes mellitus and antipsychotic treatment in a geriatric population in the United States

1 reference

12 December 2020

A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States

1 reference

12 December 2020

Antipsychotic-induced type 2 diabetes: evidence from a large health plan database

1 reference

12 December 2020

Antipsychotic-induced weight gain: a comprehensive research synthesis

1 reference

12 December 2020

Practice guideline for the treatment of patients with bipolar disorder (revision)

1 reference

12 December 2020

The implications of weight changes with antipsychotic treatment

1 reference

12 December 2020

Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia

1 reference

12 December 2020

10.1007/S00127-007-0222-Z

Identifiers

DOI

1 reference

17 April 2018

1 reference

17 April 2018